Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs
- PMID: 864285
- DOI: 10.1093/infdis/135.6.888
Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs
Abstract
Protection against experimental cholera after immunization with a purified glutaraldehyde toxoid given subcutaneously (sc), orally, or by a combined sc-oral sequence was compared in dogs. The protection induced by toxoid appeared to be entirely due to antitoxin. Repeated sc immunization with precipitated toxoid resulted in 77% protection at two weeks but no protection at four months. Protection after sc immunization correlated with titers of antitoxin in serum and appeared to result entirely from serum-derived antibody. In contrast, immunization by the sc-oral sequence resulted in prolonged protection (74% at two weeks, P=0.04; 100% after four months, P=0.004; and 57% after eight months, P=0.01) that was not related to the low serum antitoxin titers achieved. This sequence was effective only if the oral booster was given in divided doses. Immunization by oral priming and boosting was ineffective. These results suggest that the sc-oral sequence of immunization is an efficient means of stimulating the enteric immune response to nonreplicating protein antigens and may provide an improved approach to immunization against cholera.
Similar articles
-
Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid.Ciba Found Symp. 1976;(42):129-47. doi: 10.1002/9780470720240.ch8. Ciba Found Symp. 1976. PMID: 1086763
-
Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.Bull World Health Organ. 1973;49(6):605-13. Bull World Health Organ. 1973. PMID: 4548387 Free PMC article.
-
Immune response of the intestinal mucosa to cholera toxoid.J Infect Dis. 1977 Aug;136 Suppl:S113-7. doi: 10.1093/infdis/136.supplement.s113. J Infect Dis. 1977. PMID: 894085
-
Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.Scand J Infect Dis Suppl. 1990;76:47-53. Scand J Infect Dis Suppl. 1990. PMID: 2102020 Review.
-
Cholera: new aids in treatment and prevention.Science. 1973 Feb 9;179(4073):552-5. doi: 10.1126/science.179.4073.552-a. Science. 1973. PMID: 4346824 Review. No abstract available.
Cited by
-
Successful experimental challenge of dogs with canine parvovirus-2.Can J Comp Med. 1982 Jan;46(1):33-8. Can J Comp Med. 1982. PMID: 6280819 Free PMC article.
-
Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.Infect Immun. 1982 Sep;37(3):1086-92. doi: 10.1128/iai.37.3.1086-1092.1982. Infect Immun. 1982. PMID: 7129629 Free PMC article.
-
Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India.PLoS One. 2014 Jul 1;9(7):e99381. doi: 10.1371/journal.pone.0099381. eCollection 2014. PLoS One. 2014. PMID: 24983989 Free PMC article. Clinical Trial.
-
IgA antibodies in the bile of rats. II. Evidence for immunological memory in secretory immunity.Immunology. 1982 Jan;45(1):177-82. Immunology. 1982. PMID: 7056564 Free PMC article.
-
Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres.Infect Immun. 1983 Feb;39(2):1000-3. doi: 10.1128/iai.39.2.1000-1003.1983. Infect Immun. 1983. PMID: 6339378 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources